83 FR 37524 - Importer of Controlled Substances Application: Cody Laboratories Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 148 (August 1, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 148 (August 1, 2018)
| Page Range | 37524-37525 | |
| FR Document | 2018-16467 |
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)] [Notices] [Pages 37524-37525] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-16467] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Cody Laboratories Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 31, 2018. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 31, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and request for hearing on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 20, 2018, Cody Laboratories, Inc., Steve Hartman, 601 Yellowstone Avenue, Cody, Wyoming 82414-9221 applied to be registered as an importer of the following basic classes of controlled substances: [[Page 37525]] ------------------------------------------------------------------------ Drug Controlled substance code Schedule ------------------------------------------------------------------------ Phenylacetone.......................... 8501 II Poppy Straw Concentrate................ 9670 II Tapentadol............................. 9780 II ------------------------------------------------------------------------ The company plans to import narcotic raw materials to manufacture bulk controlled substances for distribution to its customers. The company plans to import an intermediate form of tapentadol (9780), to bulk manufacture tapentadol for distribution to its customers. Dated: July 23, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-16467 Filed 7-31-18; 8:45 am] BILLING CODE 4410-09-P
![37524 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
Controlled substance Drug code Schedule
Cocaine .................................................................................................................................................................... 9041 II
Codeine .................................................................................................................................................................... 9050 II
Etorphine HCl .......................................................................................................................................................... 9059 II
Dihydrocodeine ........................................................................................................................................................ 9120 II
Oxycodone ............................................................................................................................................................... 9143 II
Hydromorphone ....................................................................................................................................................... 9150 II
Diphenoxylate .......................................................................................................................................................... 9170 II
Ecgonine .................................................................................................................................................................. 9180 II
Ethylmorphine .......................................................................................................................................................... 9190 II
Hydrocodone ............................................................................................................................................................ 9193 II
Levomethorphan ...................................................................................................................................................... 9210 II
Levorphanol ............................................................................................................................................................. 9220 II
Isomethadone .......................................................................................................................................................... 9226 II
Meperidine ............................................................................................................................................................... 9230 II
Meperidine intermediate-A ....................................................................................................................................... 9232 II
Meperidine intermediate-B ....................................................................................................................................... 9233 II
Meperidine intermediate-C ...................................................................................................................................... 9234 II
Methadone ............................................................................................................................................................... 9250 II
Methadone intermediate .......................................................................................................................................... 9254 II
Metopon ................................................................................................................................................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II
Morphine .................................................................................................................................................................. 9300 II
Thebaine .................................................................................................................................................................. 9333 II
Dihydroetorphine ...................................................................................................................................................... 9334 II
Levo-alphacetylmethadol ......................................................................................................................................... 9648 II
Oxymorphone .......................................................................................................................................................... 9652 II
Noroxymorphone ..................................................................................................................................................... 9668 II
Phenazocine ............................................................................................................................................................ 9715 II
Thiafentanil .............................................................................................................................................................. 9729 II
Piminodine ............................................................................................................................................................... 9730 II
Racemethorphan ..................................................................................................................................................... 9732 II
Racemorphan .......................................................................................................................................................... 9733 II
Alfentanil .................................................................................................................................................................. 9737 II
Remifentanil ............................................................................................................................................................. 9739 II
Sufentanil ................................................................................................................................................................. 9740 II
Carfentanil ................................................................................................................................................................ 9743 II
Tapentadol ............................................................................................................................................................... 9780 II
Bezitramide .............................................................................................................................................................. 9800 II
Fentanyl ................................................................................................................................................................... 9801 II
Moramide-intermediate ............................................................................................................................................ 9802 II
The company plans to manufacture may also file a written request for a SUPPLEMENTARY INFORMATION: The
small quantities of the listed controlled hearing on the application pursuant to Attorney General has delegated his
substances in bulk for distribution to its 21 CFR 1301.43 on or before August 31, authority under the Controlled
customers. 2018. Substances Act to the Administrator of
Dated: July 23, 2018. the Drug Enforcement Administration
ADDRESSES: Written comments should (DEA), 28 CFR 0.100(b). Authority to
John J. Martin, be sent to: Drug Enforcement exercise all necessary functions with
Assistant Administrator. Administration, Attention: DEA Federal respect to the promulgation and
[FR Doc. 2018–16468 Filed 7–31–18; 8:45 am] Register Representative/DRW, 8701 implementation of 21 CFR part 1301,
BILLING CODE 4410–09–P Morrissette Drive, Springfield, Virginia incident to the registration of
22152. All requests for hearing must be manufacturers, distributors, dispensers,
sent to: Drug Enforcement importers, and exporters of controlled
DEPARTMENT OF JUSTICE
Administration, Attn: Administrator, substances (other than final orders in
Drug Enforcement Administration 8701 Morrissette Drive, Springfield, connection with suspension, denial, or
Virginia 22152. All request for hearing revocation of registration) has been
[Docket No. DEA–392] redelegated to the Assistant
should also be sent to: (1) Drug
Importer of Controlled Substances Enforcement Administration, Attn: Administrator of the DEA Diversion
Application: Cody Laboratories Inc. Hearing Clerk/LJ, 8701 Morrissette Control Division (‘‘Assistant
Drive, Springfield, Virginia 22152; and Administrator’’) pursuant to section 7 of
ACTION: Notice of application. (2) Drug Enforcement Administration, 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
sradovich on DSK3GMQ082PROD with NOTICES
Attn: DEA Federal Register
DATES: Registered bulk manufacturers of Representative/DRW, 8701 Morrissette 1301.34(a), this is notice that on June
the affected basic classes, and Drive, Springfield, Virginia 22152. 20, 2018, Cody Laboratories, Inc., Steve
applicants therefore, may file written Hartman, 601 Yellowstone Avenue,
Comments and request for hearing on
comments on or objections to the Cody, Wyoming 82414–9221 applied to
applications to import narcotic raw
issuance of the proposed registration in be registered as an importer of the
accordance with 21 CFR 1301.34(a) on material are not appropriate. 72 FR 3417 following basic classes of controlled
or before August 31, 2018. Such persons (January 25, 2007). substances:
VerDate Sep<11>2014 20:07 Jul 31, 2018 Jkt 244001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/83_FR_37672/page/1.svg)
![Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37525
Drug respect to the promulgation and Hearing Clerk/LJ, 8701 Morrissette
Controlled substance Schedule
code implementation of 21 CFR part 1301, Drive, Springfield, Virginia 22152; and
incident to the registration of (2) Drug Enforcement Administration,
Phenylacetone ................ 8501 II manufacturers, distributors, dispensers, Attn: DEA Federal Register
Poppy Straw Con- 9670 II importers, and exporters of controlled Representative/DRW, 8701 Morrissette
centrate.
substances (other than final orders in Drive, Springfield, Virginia 22152.
Tapentadol ...................... 9780 II
connection with suspension, denial, or SUPPLEMENTARY INFORMATION: The
revocation of registration) has been Attorney General has delegated his
The company plans to import narcotic
delegated to the Assistant Administrator authority under the Controlled
raw materials to manufacture bulk
of the DEA Diversion Control Division Substances Act to the Administrator of
controlled substances for distribution to
(‘‘Assistant Administrator’’) pursuant to the Drug Enforcement Administration
its customers. The company plans to
section 7 of 28 CFR part 0, appendix to (DEA), 28 CFR 0.100(b). Authority to
import an intermediate form of
subpart R. exercise all necessary functions with
tapentadol (9780), to bulk manufacture In accordance with 21 CFR
tapentadol for distribution to its respect to the promulgation and
1301.34(a), this is notice that on July 3, implementation of 21 CFR part 1301,
customers. 2018, Galephar Pharmaceutical incident to the registration of
Dated: July 23, 2018. Research Inc., #100 Carr 198 Industrial manufacturers, distributors, dispensers,
John J. Martin, Park, Juncos, Puerto Rico 00777 applied importers, and exporters of controlled
Assistant Administrator. to be registered as an importer of the substances (other than final orders in
[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am] following basic class of controlled connection with suspension, denial, or
BILLING CODE 4410–09–P substance: revocation of registration) has been
redelegated to the Assistant
Drug
Controlled substance code Schedule Administrator of the DEA Diversion
DEPARTMENT OF JUSTICE Control Division (‘‘Assistant
Hydromorphone .............. 9150 II Administrator’’) pursuant to section 7 of
Drug Enforcement Administration 28 CFR part 0, appendix to subpart R.
[Docket No. DEA–392] The company plans to import the In accordance with 21 CFR
listed controlled substance in finished 1301.34(a), this is notice that on April
Importer of Controlled Substances dosage form for clinical trials, research 4, 2018, Ultra Scientific Inc., 250 Smith
Application: Galephar Pharmaceutical and analytical purposes. Street, North Kingstown, Rhode Island
Research Inc. Dated: July 23, 2018. 02852 applied to be registered as an
John J. Martin, importer of the following basic classes
ACTION: Notice of application. of controlled substances:
Assistant Administrator.
DATES: Registered bulk manufacturers of [FR Doc. 2018–16466 Filed 7–31–18; 8:45 am] Drug
Controlled substance Schedule
the affected basic classes, and BILLING CODE 4410–09–P code
applicants therefore, may file written
comments on or objections to the Marihuana ....................... 7360 I
DEPARTMENT OF JUSTICE Tetrahydrocannabinols ... 7370 I
issuance of the proposed registration on
or before August 31, 2018. Such persons The company plans to import
Drug Enforcement Administration
may also file a written request for a derivatives of the listed controlled
hearing on the application on or before [Docket No. DEA–392]
substances for use as chemical
August 31, 2018. standards for testing and calibration
Importer of Controlled Substances
ADDRESSES: Written comments should only of analytical equipment. The above
Application: Ultra Scientific Inc.
be sent to: Drug Enforcement controlled substances will not be
Administration, Attention: DEA Federal ACTION: Notice of application. imported for human or animal
Register Representative/DRW, 8701 consumption.
Morrissette Drive, Springfield, Virginia DATES: Registered bulk manufacturers of Dated: July 23, 2018.
22152. All requests for hearing must be the affected basic classes, and
John J. Martin,
sent to: Drug Enforcement applicants therefore, may file written
Administration, Attn: Administrator, Assistant Administrator.
comments on or objections to the
8701 Morrissette Drive, Springfield, issuance of the proposed registration on [FR Doc. 2018–16465 Filed 7–31–18; 8:45 am]
Virginia 22152. All request for hearing or before August 31, 2018. Such persons BILLING CODE 4410–09–P
should also be sent to: (1) Drug may also file a written request for a
Enforcement Administration, Attn: hearing on the application on or before
Hearing Clerk/LJ, 8701 Morrissette August 31, 2018. DEPARTMENT OF JUSTICE
Drive, Springfield, Virginia 22152; and ADDRESSES: Written comments should Drug Enforcement Administration
(2) Drug Enforcement Administration, be sent to: Drug Enforcement
Attn: DEA Federal Register Administration, Attention: DEA Federal [Docket No. DEA–392]
Representative/DRW, 8701 Morrissette Register Representative/DRW, 8701
Drive, Springfield, Virginia 22152. Importer of Controlled Substances
Morrissette Drive, Springfield, Virginia
sradovich on DSK3GMQ082PROD with NOTICES
Application: Anderson Brecon, Inc.
SUPPLEMENTARY INFORMATION: The 22152. All requests for hearing must be
Attorney General has delegated his sent to: Drug Enforcement ACTION: Notice of application.
authority under the Controlled Administration, Attn: Administrator,
Substances Act to the Administrator of 8701 Morrissette Drive, Springfield, DATES: Registered bulk manufacturers of
the Drug Enforcement Administration Virginia 22152. All request for hearing the affected basic classes, and
(DEA), 28 CFR 0.100(b). Authority to should also be sent to: (1) Drug applicants therefore, may file written
exercise all necessary functions with Enforcement Administration, Attn: comments on or objections to the
VerDate Sep<11>2014 20:07 Jul 31, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/83_FR_37672/page/2.svg)
Document Created: 2018-08-01 01:22:37
Document Modified: 2018-08-01 01:22:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 31, 2018. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 31, 2018. | |
| FR Citation | 83 FR 37524 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR